BACKGROUND: Rapid blood culture diagnostics are of unclear benefit for patients with gram-negative bacilli (GNB) bloodstream infections (BSIs). We conducted a multicenter, randomized, controlled trial comparing outcomes of patients with GNB BSIs who had blood culture testing with standard-of-care (SOC) culture and antimicrobial susceptibility testing (AST) vs rapid organism identification (ID) and phenotypic AST using the Accelerate Pheno System (RAPID). METHODS:Patients with positive blood cultures with Gram stains showing GNB were randomized to SOC testing with antimicrobial stewardship (AS) review or RAPID with AS. The primary outcome was time to first antibiotic modification within 72 hours of randomization. RESULTS: Of 500 randomized patients, 448 were included (226 SOC, 222 RAPID). Mean (standard deviation) time to results was faster for RAPID than SOC for organism ID (2.7 [1.2] vs 11.7 [10.5] hours; P < .001) and AST (13.5 [56] vs 44.9 [12.1] hours; P < .001). Median (interquartile range [IQR]) time to first antibiotic modification was faster in the RAPID arm vs the SOC arm for overall antibiotics (8.6 [2.6-27.6] vs 14.9 [3.3-41.1] hours; P = .02) and gram-negative antibiotics (17.3 [4.9-72] vs 42.1 [10.1-72] hours; P < .001). Median (IQR) time to antibiotic escalation was faster in the RAPID arm vs the SOC arm for antimicrobial-resistant BSIs (18.4 [5.8-72] vs 61.7 [30.4-72] hours; P = .01). There were no differences between the arms in patient outcomes. CONCLUSIONS: Rapid organism ID and phenotypic AST led to faster changes in antibiotic therapy for gram-negative BSIs. CLINICAL TRIALS REGISTRATION: NCT03218397.
RCT Entities:
BACKGROUND: Rapid blood culture diagnostics are of unclear benefit for patients with gram-negative bacilli (GNB) bloodstream infections (BSIs). We conducted a multicenter, randomized, controlled trial comparing outcomes of patients with GNB BSIs who had blood culture testing with standard-of-care (SOC) culture and antimicrobial susceptibility testing (AST) vs rapid organism identification (ID) and phenotypic AST using the Accelerate Pheno System (RAPID). METHODS:Patients with positive blood cultures with Gram stains showing GNB were randomized to SOC testing with antimicrobial stewardship (AS) review or RAPID with AS. The primary outcome was time to first antibiotic modification within 72 hours of randomization. RESULTS: Of 500 randomized patients, 448 were included (226 SOC, 222 RAPID). Mean (standard deviation) time to results was faster for RAPID than SOC for organism ID (2.7 [1.2] vs 11.7 [10.5] hours; P < .001) and AST (13.5 [56] vs 44.9 [12.1] hours; P < .001). Median (interquartile range [IQR]) time to first antibiotic modification was faster in the RAPID arm vs the SOC arm for overall antibiotics (8.6 [2.6-27.6] vs 14.9 [3.3-41.1] hours; P = .02) and gram-negative antibiotics (17.3 [4.9-72] vs 42.1 [10.1-72] hours; P < .001). Median (IQR) time to antibiotic escalation was faster in the RAPID arm vs the SOC arm for antimicrobial-resistant BSIs (18.4 [5.8-72] vs 61.7 [30.4-72] hours; P = .01). There were no differences between the arms in patient outcomes. CONCLUSIONS: Rapid organism ID and phenotypic AST led to faster changes in antibiotic therapy for gram-negative BSIs. CLINICAL TRIALS REGISTRATION: NCT03218397.
Authors: Thomas P Lodise; Nimish Patel; Andrea Kwa; Jeffrey Graves; Jon P Furuno; Eileen Graffunder; Ben Lomaestro; Jessina C McGregor Journal: Antimicrob Agents Chemother Date: 2007-07-23 Impact factor: 5.191
Authors: Katherine K Perez; Randall J Olsen; William L Musick; Patricia L Cernoch; James R Davis; Leif E Peterson; James M Musser Journal: J Infect Date: 2014-05-17 Impact factor: 6.072
Authors: Megan M Seddon; P Brandon Bookstaver; Julie Ann Justo; Joseph Kohn; Hana Rac; Emily Haggard; Krutika N Mediwala; Sangita Dash; Majdi N Al-Hasan Journal: Clin Infect Dis Date: 2019-07-18 Impact factor: 9.079
Authors: Brandon J Webb; Aruna Subramanian; Bert Lopansri; Bruce Goodman; Peter Bjorn Jones; Jeffrey Ferraro; Edward Stenehjem; Samuel M Brown Journal: Antimicrob Agents Chemother Date: 2020-03-24 Impact factor: 5.191
Authors: Katherine K Perez; Randall J Olsen; William L Musick; Patricia L Cernoch; James R Davis; Geoffrey A Land; Leif E Peterson; James M Musser Journal: Arch Pathol Lab Med Date: 2012-12-06 Impact factor: 5.534
Authors: Melissa B Miller; Faranak Atrzadeh; C A Burnham; Stephen Cavalieri; James Dunn; Stephen Jones; Charles Mathews; Peggy McNult; John Meduri; Chris Newhouse; Duane Newton; Michael Oberholzer; John Osiecki; David Pedersen; Nicole Sweeney; Natalie Whitfield; Joe Campos Journal: J Clin Microbiol Date: 2019-08-26 Impact factor: 5.948
Authors: Federico Perez; Roberto Viau Colindres; Brigid M Wilson; Elie Saade; Robin L P Jump; Ritu Banerjee; Robin Patel; Scott R Evans; Robert A Bonomo Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079
Authors: Matthias Klein; Johannes Bacher; Sandra Barth; Faranak Atrzadeh; Katja Siebenhaller; Inês Ferreira; Stephan Beisken; Andreas E Posch; Karen C Carroll; Richard G Wunderink; Chao Qi; Fann Wu; Dwight J Hardy; Robin Patel; Matthew D Sims Journal: J Clin Microbiol Date: 2021-02-18 Impact factor: 5.948
Authors: Alyssa B Christensen; Brent Footer; Tobias Pusch; Kim Heath; Maha Iqbal; Lian Wang; Gregory Tallman; Cameron Cover; Jennifer Marfori; Brian Kendall; Nick Stucky; Meagan Greckel; Ivor L Thomas; Katelynn Tran; Salena Yip; Margret Oethinger Journal: Open Forum Infect Dis Date: 2022-07-22 Impact factor: 4.423